• Symposium
  • Free Paper Session
  • Luncheon & Sponsored Symposium

March 18 (Friday)

Symposium 1: Where Will Artificial Intelligence Lead Human Beings?

Date & Time March 18 (Friday), 09:00 - 10:20
Chairs Moon Kyung Joo (Korea University, Korea)
Yuichi Mori (Showa University, Japan)
Speakers 09:00 - 09:20 Artificial intelligence endoscopy: How far? And Where to?
Yuichi Mori (Showa University, Japan)
09:20 - 09:40 Challenges and opportunities of digital pathology
Kyu-Hwan Jung (VUNO, Korea)
09:40 - 10:00 Artificial intelligence and data-driven precision medicine in gastric cancer
Tae Hyun Hwang (Mayo Clinic, USA)
10:00 - 10:20 Lessons from artificial intelligence: Gastroenterologist's perspective
Chang Seok Bang (Hallym University, Korea)

Symposium 2. Bright and Dark Sides of Acid Suppressants: Dispute and Truth

Date & Time March 18 (Friday), 10:40 - 12:00
Chairs Jae J. Kim (Sungkyunkwan University, Korea)
Takahisa Furuta (Hamamatsu University, Japan)
Speakers 10:40-11:00 Long-term PPI therapy and risk of gastrointestinal cancer
Seung In Seo (Hallym University, Korea)
11:00-11:20 Long-term risks and complications of P-CAB intake
Takahisa Furuta (Hamamatsu University, Japan)
11:20-11:40 PPI use and duodenal inflammation in functional dyspepsia
Lucas Wauters (University Hospitals Leuven, Belgium)
11:40-12:00 Acid suppression and clinical outcomes in COVID-19: PPI vs. famotidine
In Kyung Yoo (CHA University, Korea)

Symposium 3. Exploring Microbiome in Gastrointestinal Diseases

Date & Time March 18 (Friday), 13:00 - 14:20
Chairs Yong Chan Lee (Yonsei University, Korea)
Nadeem O. Kaakoush (University of New South Wales, Australia)
Speakers 13:00 - 13:20 Salivary microbiome: Is it connected to gastrointestinal disease?
Yoshihisa Yamashita (Kyushu University, Japan)
13:20 - 13:40 Esophageal microbiome in GERD and metaplasia: A key player or innocent bystander?
Nadeem O. Kaakoush (University of New South Wales, Australia)
13:40 - 14:00 A long journey of the gastric microbiome: Aging and H. pylori eradication
Cheol Min Shin (Seoul National University, Korea)
14:00 - 14:20 Live biotherapeutic products in the treatment of human cancer
Hansoo Park (Gwangju Institute of Science and Technology (GIST), Korea)

Symposium 4. Asian Topic Forum: Current Use of Acid Suppressants (PPI, P-CAB, and H2 blocker)

Date & Time March 18 (Friday), 15:20 - 16:50
Chairs Jae Gyu Kim (Chung-Ang University, Korea)
Varocha Mahachai (Thammasat University, Thailand)
Speakers 15:20 -15:30 Current use of acid suppressants in Thailand
Varocha Mahachai (Thammasat University, Thailand)
15:30 - 15:40 Current use of acid suppressants in Myanmar
Than Than Aye (University of Medicine 1 Yangon, Myanmar)
15:40-15:50 Current use of acid suppressants in Singapore
Tiing Leong Ang (Changi General Hospital, Singapore)
15:50 - 16:00 Current use of acid suppressants in Philippines
Jose D. Sollano (University of Santo Tomas, Philippines)
16:00 - 16:10 Current use of acid suppressants in Vietnam
Vu Van Khien (108 Military Central Hospital, Vietnam)
16:10 - 16:20 Current use of acid suppressants in Malaysia
Alex Hwong Ruey Leow (University of Malaya, Malaysia)
16:20 - 16:30 Current use of acid suppressants in Mongolia
Sarantuya Gidaagaya (Intermed Hospital, Mongolia)
16:30 - 16:40 Current use of acid suppressants in Indonesia
Marcellus Simadibrata (University of Indonesia, Indonesia)
16:40 - 16:50 Discussion

March 19 (Saturday)

Symposium 5: PUD: Diagnosis, Prevention, Complications, and More

Date & Time March 19 (Saturday), 11:10 - 12:30
Chairs Nayoung Kim (Seoul National University, Korea)
Joseph Sung (Nanyang Technology University, Singapore)
Speakers 11:10 - 11:30 Pathophysiology and risk factors in PUD
Joseph Sung (Nanyang Technology University, Singapore)
11:30 - 11:50 Diagnostic and medical treatment approaches for idiopathic/refractory PUD
Takeshi Kanno (Tohoku University, Japan)
11:50 - 12:10 Prevention and treatment strategy of PUD associated with aspirin and antiplatelet agent
Joon Sung Kim (The Catholic University of Korea, Korea)
12:10 - 12:30 Endoscopic treatment of complications of PUD
Da Hyun Jung (Yonsei University, Korea)

Symposium 6: Optimized Diagnosis and Management for H. pylori and Recent Update of H. pylori Registry

Date & Time March 19 (Saturday), 15:40 - 17:00
Chairs Hwoon-Yong Jung (University of Ulsan, Korea)
Javier P. Gisbert (Universidad Autónoma de Madrid, Spain)
Speakers 15:40 - 16:00 When and how to test antibiotic resistance before H. pylori eradication in USA?
Shailja C. Shah (University of California San Diego, USA)
16:00 -16:20 When and how to test antibiotic resistance before H. pylori eradication in Japan?
Sho Suzuki (Nihon University, Japan)
16:20 - 16:40 The results and further plans of European H. pylori registry
Javier P. Gisbert (Hospital Universitario de La Princesa, Spain)
16:40- 17:00 The interim results and things to consider of the Korean H. pylori registry
Hyo-Joon Yang (Sungkyunkwan University, Korea)

March 19 (Saturday)

Free Paper 1

Date & Time March 19 (Saturday), 08:50 - 09:30 (Room A)
Chairs Sung Soo Kim (The Catholic University of Korea, Korea)
Jun Haeng Lee (Sungkyunkwan University, Korea)
Speakers 08:50 - 09:00 Efficacy of Helicobacter pylori treatment in Vietnam over 10 years from 2011 to 2021
Doan Nguyen (University of Pharmacy and Medicine, Vietnam)
09:00 - 09:10 Vonoprazan based triple and high dose dual therapies are effective in the primary eradication of H. pylori infection - An interim analysis
Khoo Stanley (University of Malaya, Malaysia)
09:10 - 09:20 Effect of prior dosage of azithromycin on Helicobacter pylori eradication therapy
Se in Hah (Gyeongsang National University, Korea)
09:20 - 09:30 A polygenic risk score of Helicobacter pylori for risk prediction of gastric cancer
Xiaoyu Wang (Qingdao University, China)

Free Paper 2

Date & Time March 19 (Saturday), 08:50 - 09:30 (Room B)
Chairs Joo Young Cho (CHA University, Korea)
Su Jin Hong (Soonchunhyang University, Korea)
Speakers 08:50 - 09:00 Deep-learning for the diagnosis of esophageal cancers and precursor lesions in endoscopic images: A model establishment and nationwide multicenter performance verification study
Eun Jeong Gong (University of Ulsan, Korea)
09:00 - 09:10 Tumor budding is important to predict the risk of lymph node metastasis in early gastric cancer
Yeonjin Je (Yonsei University, Korea)
09:10 - 09:20 Nomogram for pre-procedural prediction of non-curative endoscopic resection in early gastric cancer patients
So Young Han (Yonsei University, Korea)
09:20 - 09:30 Antibiotics resistance of Helicobacter pylori and treatment outcome of peptic ulcer in Vietnamese children
Thi Viet Ha Nguyen (Hanoi Medical University, Vietnam)

Free Paper 3

Date & Time March 19 (Saturday), 09:30 - 10:10 (Room A)
Chairs Hyun Yong Jeong (Chungnam National University, Korea)
Ki-Nam Shim (Ewha Womans University, Korea)
Speakers 09:30 - 09:40 Comparison of the efficacies of standard triple, sequential and quadruple antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial
Mohd Imran Chouhan (All India Institute of Medical Sciences, India)
09:40 - 09:50 The Efficacy of 10 days of tegoprazan based non-bismuth containing quadruple therapies on the first-line Helicobacter pylori eradication
Yong Hwan Kwon (Kyungpook National University, Korea)
09:50 - 10:00 Factors associated with successful eradication in patients with multiple Helicobacter pylori treatment failures: A population-based study
Natsuda Aumpan (Thammasat University, Thailand)
10:00 - 10:10 Zinc Carnosine-based modified bismuth quadruple therapy versus standard triple therapy for Helicobacter pylori eradication: A prospective open-label randomized study
Ali Choukair (Clemenceau Medical Center, United Arab Emirates)

Free Paper 4

Date & Time March 19 (Saturday), 09:30 - 10:10 (Room B)
Chairs Ok-Jae Lee (Gyeongsang National University, Korea)
Suck Chei Choi (Wonkwang University, Korea)
Speakers 09:30 - 09:40 Helicobacter pylori isolates from Mongolia describing gastric carcinogenesis and human migration
Boldbaatar Gantuya (Mongolian National University, Mongolia)
09:40 - 09:50 Histamine-2 receptor antagonists and proton pump inhibitors are associated with decreased incidence of COVID-19 in patients without comorbidities including diabetes, hypertension, and dyslipidemia: A propensity score-matched nationwide cohort study
Bokyung Kim (Seoul National University, Korea)
09:50 - 10:00 Changes in the proportion of gastrointestinal emergency endoscopy and peptic ulcer disease during the COVID-19 pandemic: A local retrospective observational study from Vietnam
Hang Dao (Hanoi Medical University, Vietnam)
10:00 - 10:10 High dose local-made oral omeprazole versus standard continuous intravenous pantoprazole in patient with peptic ulcer bleeding underwent successful therapeutic endoscopy; Non-inferiority randomized trial: A preliminary result
Kanteera Sriyudthsak (Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thailand)

Free Paper 5

Date & Time March 19 (Saturday), 10:10 - 10:50 (Room A)
Chairs Jeong Seop Moon (Inje University, Korea)
Gwang Ho Baik (Hallym University, Korea)
Speakers 10:10 - 10:20 Efficacy of a novel PCR method (Allplex™ H.pylori & ClariR Assay) for Helicobacter pylori eradication
Ilsoo Kim (The Catholic University of Korea, Korea)
10:20 - 10:30 Real-time polymerase chain reaction for detection of Helicobacter pylori and clarithromycin resistance
Jin Hee Noh (University of Ulsan, Korea)
10:30 - 10:40 Time-trend and endoscopic-pathological characteristics of early-onset gastric carcinoma in Vietnamese: A single-hospital experience
Lan Tran Thi Ngoc (An Binh Hospital, Vietnam)
10:40 - 10:50 Gastric cancer in elderly patients
Yonghoon Choi (Seoul National University, Korea)

Free Paper 6

Date & Time March 19 (Saturday), 10:10 - 10:50 (Room B)
Chairs Kwang Jae Lee (Ajou University, Korea)
Moo In Park (Kosin University, Korea)
Speakers 10:10 - 10:20 Altered gastric microbiota and inflammatory cytokine responses in patients with Helicobacter pylori-negative gastric dysplasia and cancer
Hyo-Joon Yang (Sungkyunkwan University, Korea)
10:20 - 10:30 Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis
Jae Yong Park (Chung-Ang University, Korea)
10:30 - 10:40 Symptom response in patients with functional dyspepsia after rifaximin treatment
Nang Khin Phone Tint (Yangon General Hospital, Myanmar)
10:40 - 10:50 MicroRNA expression in plasma of esophageal squamous cell carcinoma patients
Dong Chan Joo (Pusan National University, Korea)

Plenary Session

Date & Time March 19 (Saturday), 14:20 - 15:20
Chairs Soo-Heon Park (The Catholic University of Korea, Korea)
Sung Kook Kim (Kyungpook National University, Korea)
Speakers 14:20 - 14:35 Eradication rates and cost analysis between the empirical concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial
Sujin Kim (Pusan National University, Korea)
14:35 - 14:50 The proportion of mixed carcinoma and its effect on the prognosis of 7,215 patients with gastric cancer
Hyeong Ho Jo (Seoul National University, Korea)
14:50 - 15:05 Idenification of exosomal lncRNA, Linc00853 involved in gastric cancer development and carcinogenic mechanism through PDZK1-AKT-MAP17 pathway
Hyo Joo Byun (Yonsei University, Korea)
15:05 - 15:20 Immune microarchitectural changes in regional lymph nodes after chemotherapy in oesophageal cancer - results from the UK MRC OE02 trial
Maximilian Kloft (Maastricht University Medical Centre, Nertherlands)

March 18 (Friday)

Luncheon Symposium (inno.N)

Date & Time March 18 (Friday), 12:00-13:00
Chair Dong Ho Lee (Seoul National University, Korea)
Speaker Tegoprazan, the novel advance in the management of upper gastrointestinal disease
Yong Hwan Kwon (Kyungpook National University, Korea)

Sponsored Symposium 1 (Daewoong Pharmaceutical)

Date & Time March 18 (Friday), 14:20-15:00
Chair Byung Chul Yoon (Hanyang University, Korea)
Speaker Fexuprazan, the new wave of GI treatment
Gwang Ha Kim (Pusan National University, Korea)

Sponsored Forum 1 (Otsuka Pharmaceutical Co., Ltd.)

Date & Time March 18 (Friday), 17:00-18:00
Chairs Hyungkil Kim (Inha University, Korea)
Sam Ryong Jee (Inje University, Korea)
Speakers 17:00-17:15 Treatment of H. Pylori infected patients with the use of rebamipide
Melchor M. Chan (University of Santo Tomas Hospital, Philippines)
17:15-17:30 Benefit of rebamipide for current treatment of Gastroenteropathy due to NSAID or Aspirin
Virly Nanda Muzellina (Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Indonesia)
17:30-17:45 Optimal management for upper GI tract with Mucosta SR® 150mg
Hang-Lak Lee (Hanyang University, Korea)
17:45-18:00 New paradigm shift & post treatment follow-up of H. Pylori infection
Ahn Ji Yong (University of Ulsan, Korea)

Sponsored Forum 2 (YUHAN)

Date & Time March 19 (Saturday), 08:00 - 08:30
Chair Sang-Yong Seol (Inje University, Korea)
Speaker Commitment to patient compliance: Recomid SR tab (Rebamipide 150mg)
Jeong Hwan Kim (Konkuk University, Korea)

Sponsored Symposium 2 (JEIL PHARMACEUTICAL CO.,LTD)

Date & Time March 19 (Saturday), 13:30 - 14:20
Chair Jong-Jae Park (Korea University, Korea)
Speaker Treatment option for refractory GERD; Focused on dexlansoprazole DR and tianeptine
Byung-Wook Kim (The Catholic University of Korea, Korea)